skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 3
Patent #:
Issue Dt:
05/19/2020
Application #:
15777495
Filing Dt:
05/18/2018
Publication #:
Pub Dt:
11/15/2018
Inventors:
Corinne LEBRETON, Francois-Xavier MAUVAIS, Pascale DE LONLAY-DEBENEY, Yamina HAMEL et al
Title:
METHODS AND PHARMACEUTICAL COMPOSTIONS FOR TREATING RHABDOMYOLYSIS
Assignment: 1
Reel/Frame:
051651/0198Recorded: 01/29/2020Pages: 5
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
05/25/2018
Exec Dt:
05/24/2018
Exec Dt:
05/25/2018
Exec Dt:
05/24/2018
Exec Dt:
05/24/2018
Assignees:
101, RUE DE TOLBIAC
PARIS, FRANCE 75013
24, BOULEVARD DU MONTPARNASSE
PARIS, FRANCE 75015
12, RUE DE L'ECOLE DE MÉDECINE
PARIS, FRANCE 75006
3, AVENUE VICTORIA
PARIS, FRANCE 75004
3, RUE MICHEL ANGE
PARIS, FRANCE 75016
Correspondent:
W&C IP
11491 SUNSET HILLS ROAD
SUITE 340
RESTON, VA 20190
Assignment: 2
Reel/Frame:
060044/0856Recorded: 05/12/2022Pages: 8
Conveyance:
MERGER (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
01/01/2020
Assignee:
85 BOULEVARD SAINT-GERMAIN
PARIS, FRANCE 75006
Correspondent:
WC&F IP
11491 SUNSET HILLS ROAD
SUITE 340
RESTON, VA 20190
Assignment: 3
Reel/Frame:
059988/0388Recorded: 05/12/2022Pages: 9
Conveyance:
CHANGE OF NAME (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
03/04/2022
Assignee:
85 BOULEVARD SAINT-GERMAIN
PARIS, FRANCE 75006
Correspondent:
WC&F IP
11491 SUNSET HILLS ROAD
SUITE 340
RESTON, VA 20190

Search Results as of: 04/27/2024 08:30 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT